Report : Cell Line Development Market to 2027 - Global Analysis and Forecasts By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography
A recombinant cell line segment is expected to hold the largest share over the forecast period
According to The Insight Partners market research titled 'Cell Line Development Market to 2027 - Global Analysis and Forecasts by Type, Product, and Application'. The global cell line development market is anticipated to reach US$ 11,161.35 Mn in 2027 from US$ 3,694.87 Mn in 2018. The cell line development market is expected to grow with a CAGR of 13.2% from 2019-2027. The report presents trends predominating in the global cell line development market and the factors driving the market and also the factors that act as hindrances.
The global cell line development market, based on the type, was segmented into a primary cell line, hybridomas, continuous cell lines, and recombinant cell line. In 2018, the recombinant cell line accounted for the largest market share in the global cell line development market by type. The recombinant cell line segment is expected to witness rapid growth owing to critical factors like the rising demand for recombinant proteins, increasing the use of recombinant cell lines for biotherapeutics, and growing demand for toxicity testing.
The significant factors fueling market growth are the increasing adoption of regenerative medicines, rising prevalence of cancer across the globe, and increasing investments in R&D by pharmaceutical and biotechnology companies. Also, middle-income countries creating development opportunities are likely to have a positive influence on market growth in the coming years.
The cell line development market majorly consists of players such as Thermo Fisher Scientific Inc., Merck KGaA, Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXi AppTec Group among others. Several companies are concentrating on organic strategies, such as product launch and product approvals. For instance, in June 2019, Thermo Fisher Scientific introduced Cytomat 2 C-LiN Series automated incubator for cell cultures. This instrument has features such as controlled automatic humidity, inbuilt contamination reduction system, other advanced features.
Global Cell Line Development Market, By Regions, 2018 (%)
The report segments the global cell line development market as follows:
Global Cell Line Development Market - By Type
Global Cell Line Development Market - By Product
Global Cell Line Development Market - By Application
Global Cell Line Development Market - By Geography
Contact Person: Sameer Joshi
Email Id: email@example.com